Iterum Therapeutics Reports Second Quarter 2023 Financial Results
--Expect to Complete Enrollment in Q1 2024; Topline Data Expected in Q2 2024 -- --Cash Runway into Q3 2024-- DUBLIN, Ireland and CHICAGO, Aug. 11, 2023 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (Iterum), a clinical-stage pharmaceutical …